NHS approves at-home heart injection for rare condition
A new at-home injection for a rare heart condition, transthyretin amyloidosis, has been approved for NHS use in England and Wales, offering hope to 1,500 patients.
A new at-home injection for a rare heart condition, transthyretin amyloidosis, has been approved for NHS use in England and Wales, offering hope to 1,500 patients.